STOCK TITAN

TAO Synergies Inc Financials

TAOX
Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows TAO Synergies Inc (TAOX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Weak
2/9

TAO Synergies Inc passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass.

Earnings Quality Low Quality
0.38x

For every $1 of reported earnings, TAO Synergies Inc generates $0.38 in operating cash flow (-$4.9M OCF vs -$12.8M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV
Revenue
N/A
EBITDA
N/A
Free Cash Flow
N/A
Net Income
-$12.8M
YoY-111.5%

TAO Synergies Inc reported -$12.8M in net income in fiscal year 2024. This represents a decrease of 111.5% from the prior year.

EPS (Diluted)
$10.99
YoY-62.8%

TAO Synergies Inc earned $10.99 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 62.8% from the prior year.

Cash & Debt
$17.7M
YoY-38.4%
5Y CAGR+0.3%

TAO Synergies Inc held $17.7M in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share
N/A
Shares Outstanding
1M
YoY+40.9%

TAO Synergies Inc had 1M shares outstanding in fiscal year 2024. This represents an increase of 40.9% from the prior year.

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A
R&D Spending
$1.6M
YoY-19.0%
5Y CAGR-22.4%

TAO Synergies Inc invested $1.6M in research and development in fiscal year 2024. This represents a decrease of 19.0% from the prior year.

Share Buybacks
N/A
Capital Expenditures
N/A

TAOX Income Statement

Metric Q3'25 Q2'25 Q1'25 Q4'23 Q3'24 Q2'24 Q1'24 Q4'22
Revenue $203K+5033.0% $4K N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses $54K-63.4% $149K+144.3% $61K N/A $212K-31.0% $307K-65.0% $878K N/A
SG&A Expenses $1.9M-11.1% $2.2M+117.3% $1.0M N/A $1.2M-20.0% $1.5M-25.5% $2.0M N/A
Operating Income -$1.8M+40.7% -$3.0M N/A N/A N/A N/A N/A N/A
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income -$3.9M+77.6% -$17.5M-4647.6% $385K N/A $763K+118.6% -$4.1M-139.2% -$1.7M N/A
EPS (Diluted) $-1.56+86.1% $-11.26-28250.0% $0.04 N/A $0.84-39.6% $1.39+121.1% $-6.59 N/A

TAOX Balance Sheet

Metric Q3'25 Q2'25 Q1'25 Q4'23 Q3'24 Q2'24 Q1'24 Q4'22
Total Assets $18.4M-7.2% $19.8M+29.1% $15.3M-50.7% $31.1M-3.9% $32.4M-3.2% $33.4M-8.5% $36.5M-5.4% $38.6M
Current Assets $18.3M-7.2% $19.8M+29.1% $15.3M-49.8% $30.5M-5.6% $32.3M-3.2% $33.4M-8.5% $36.5M-5.4% $38.6M
Cash & Equivalents $1.4M-89.9% $14.4M-3.1% $14.8M-48.2% $28.7M-9.7% $31.7M-3.6% $32.9M-8.1% $35.8M-4.5% $37.5M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $1.7M-7.5% $1.8M-79.4% $8.9M+60.6% $5.5M+40.6% $3.9M-39.8% $6.5M+178.7% $2.3M-26.6% $3.2M
Current Liabilities $1.0M+8.1% $964K+357.7% $211K-95.1% $4.3M+135.3% $1.8M-34.4% $2.8M+117.2% $1.3M-2.7% $1.3M
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $16.1M-6.9% $17.2M+233.7% $5.2M-78.8% $24.3M-9.0% $26.7M+7.7% $24.8M-21.1% $31.5M-3.8% $32.7M
Retained Earnings -$68.5M-6.2% -$64.5M-37.6% -$46.9M-39.5% -$33.6M-3.8% -$32.4M-1.1% -$32.0M-46.8% -$21.8M-10.0% -$19.8M

TAOX Cash Flow Statement

Metric Q3'25 Q2'25 Q1'25 Q4'23 Q3'24 Q2'24 Q1'24 Q4'22
Operating Cash Flow -$1.2M-59.5% -$749K+62.6% -$2.0M-87.7% -$1.1M+9.0% -$1.2M+5.5% -$1.2M+26.9% -$1.7M+39.1% -$2.8M
Capital Expenditures N/A N/A N/A $0 $0-100.0% $669-67.2% $2K-4.7% $2K
Free Cash Flow N/A N/A N/A -$1.1M+9.0% -$1.2M+5.5% -$1.2M+27.0% -$1.7M+39.1% -$2.8M
Investing Cash Flow -$13.1M-2514.0% -$500K0.0% -$500K+75.0% -$2.0M $0+100.0% -$669+67.2% -$2K+4.7% -$2K
Financing Cash Flow $1.3M-72.0% $4.8M+681.9% -$822K-1612374.5% -$51-204.1% $49 N/A N/A $13.9M
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

TAOX Financial Ratios

Metric Q3'25 Q2'25 Q1'25 Q4'23 Q3'24 Q2'24 Q1'24 Q4'22
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin -884.8%+75738.9pp -76623.8% N/A N/A N/A N/A N/A N/A
Net Margin -1929.1%+440172.8pp -442101.9% N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A 7.4% N/A 2.9% N/A N/A N/A
Return on Assets -21.4%+67.1pp -88.5%-91.0pp 2.5% N/A 2.4%+14.6pp -12.2%-7.5pp -4.7% N/A
Current Ratio 17.61-2.9 20.51-52.2 72.71+65.6 7.14-10.7 17.79+5.7 12.05-16.5 28.59-0.8 29.39
Debt-to-Equity 0.110.0 0.11-1.6 1.72+1.5 0.23+0.1 0.15-0.1 0.26+0.2 0.07-0.0 0.10
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Similar Companies

Frequently Asked Questions

Is TAO Synergies Inc profitable?

No, TAO Synergies Inc (TAOX) reported a net income of -$12.8M in fiscal year 2024.

What is TAO Synergies Inc's earnings per share (EPS)?

TAO Synergies Inc (TAOX) reported diluted earnings per share of $10.99 for fiscal year 2024. This represents a -62.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is TAO Synergies Inc's operating cash flow?

TAO Synergies Inc (TAOX) generated -$4.9M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are TAO Synergies Inc's total assets?

TAO Synergies Inc (TAOX) had $17.7M in total assets as of fiscal year 2024, including both current and long-term assets.

How much does TAO Synergies Inc spend on research and development?

TAO Synergies Inc (TAOX) invested $1.6M in research and development during fiscal year 2024.

How many shares does TAO Synergies Inc have outstanding?

TAO Synergies Inc (TAOX) had 1M shares outstanding as of fiscal year 2024.

What is TAO Synergies Inc's current ratio?

TAO Synergies Inc (TAOX) had a current ratio of 17.47 as of fiscal year 2024, which is generally considered healthy.

What is TAO Synergies Inc's debt-to-equity ratio?

TAO Synergies Inc (TAOX) had a debt-to-equity ratio of 1.87 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is TAO Synergies Inc's return on assets (ROA)?

TAO Synergies Inc (TAOX) had a return on assets of -72.0% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is TAO Synergies Inc's cash runway?

Based on fiscal year 2024 data, TAO Synergies Inc (TAOX) had $17.7M in cash against an annual operating cash burn of $4.9M. This gives an estimated cash runway of approximately 43 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is TAO Synergies Inc's Piotroski F-Score?

TAO Synergies Inc (TAOX) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are TAO Synergies Inc's earnings high quality?

TAO Synergies Inc (TAOX) has an earnings quality ratio of 0.38x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.